PNNL-CompBio / decomprolute

A suite of scientific workflows to assess metrics to compare efficacy of protein-based tumor deconvolution algorithms.
MIT License
15 stars 3 forks source link

Discuss rough manuscript outline #35

Closed sgosline closed 2 years ago

sgosline commented 3 years ago

I think it would be helpful to allocate specific parts of the manuscript so that we can be focused about task allocation and what our ultimate goals are (and are not!).

1- Introduction

2- Results - benchmark software framework Song

3- Results - comparison of algorithms (mRNA to protein) across single matrix by correlation across patients - which cell types are most similar??? Song

4- Results - comparison across matrices (mRNA to protein) across single algorithm - which matrix works best for both mRNA and protein? song

5-Results - comparisons across tumors (mRNA to protein by patient) across matrix by correlation across cell types - which cancer types are the most similar? Song

6 - Results - Impact of protein imputation on deconvolution Anna

7- Results - flexibility of algorithms - this could be discussion Francesca

8- Results - comparison with iAtlas immune subtypes - inferred on CPTAC data. Pietro

sgosline commented 3 years ago

I'm updating the manuscript outline based on our current tests and discussions.

2- Results - extensible software framework enables facile comparison of proteomics-based deconvolution algorithms Figure 1 - framework diagram and example of description of overall, correlation, and subtype matrix.

Song

3-Results - Results on simulated data show that.... Francesca/Sara Figure 2

4- Results - Cell-type correlations confer that MCP counter is most robust between mRNA and protein comparisons Figure 3 Sara

5- Results -Immune subtype comparisons show that .... Pietro Figure 4

6 - Results - Imputation has little impact on strong-performing deconvolution algorithms Song Figure 5

7- Discussion - Value of protein deconvolution over mRNA This is a key point that we need to drive home

8- Discussion - lack of gold standard and need for more validation the rieckmann data is good but need tumor sample and cell mixing experiment

9- Discussion - ability to plug in additional algorithms/tools

sgosline commented 3 years ago

Also need to add tumor-normal comparison in supplemental.

sgosline commented 2 years ago

Manuscript is now in process on google dirve.